2017 Dialogue for Action® Toolkit
The Dialogue Toolkit contains materials to start and continue conversations with Dialogue colleagues and in your community about cancer screening and prevention.
To learn about evidence-based interventions and collaborations in communities working on cancer screening and prevention, view the posters and presentations that were presented throughout the 2017 Dialogue.
Want to discuss new cancer screening modalities or advocacy campaigns? Download the Networking Resource Guide to network with past Dialogue professionals on a variety of cancer screening issues.
Agenda
2017 Dialogue Agenda
2017 Presentations
Review presenters’ slideshows and audio recordings
2017 Conversations
Conversation 1: How to Encourage Primary-Care Clinicians to Improve HPV Vaccination Rates
Conversation 3: Strategies for Implementing Obesity Prevention Programs in Your Community
Poster Session
2017 Dialogue Posters
Networking Resource Guide
Networking Resource Guide
Supplemental Materials
FOUNDATIONS FOR PREVENTION AND EARLY DETECTION OF BREAST, CERVICAL, COLORECTAL AND LUNG CANCER
Colorectal cancer statistics, 2017
Genetic architecture of colorectal cancer
REDUCING DISPARITIES IN CANCER PREVENTION AND SCREENING
Developing a Cookbook with Lifestyle Tips: A Community-Engaged Approach to Promoting Diet-Related Cancer Prevention Guidelines
WHAT’S TRENDING IN RESEARCH ON CANCER PREVENTION AND EARLY DETECTION?
Screening trials
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years Cancer 2016 [Epub ahead of print] (PLCO trial)
Quality-of-life effects of prostate-specific antigen screening (ERSPC trial)
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial (Göteborg trial)
Screening for prostate cancer starting at age 50-54 years. A population-based cohort study (Göteborg trial, Malmö Preventive Project)
THINK ABOUT THE LINK: VIRUSES AND CANCER
Cervical Cancer Screening: Pap and Human Papilloma Virus (HPV) Testing
Human Papilloma Virus (HPV)
HPV Fact Sheet
Are you at risk for throat cancer?
Oropharyngeal Cancer and the Human Papillomavirus (HPV)
POLICY-LEVEL THOUGHTS ABOUT ACCESS TO QUALITY AFFORDABLE CARE IN POST-ACA AMERICA
Insurance Market Stability: The High-Deductible Problem
Dialogue Blog
Leading up to the 2017 conference, Dialogue speakers and attendees will be talking about their work to improve cancer screening and prevention in monthly blog posts.
Addressing equal access to preventive care in Tunisia, Apr. 4, 2017
As a member of the Tunisian Association for Defending the Right to Health, Dr. Amna Khalfaoui plans to travel from North Africa to attend this year’s Dialogue for Action® conference. Read about the challenges Tunisia faces in improving health care and what she’s most looking to take home with her from this year’s Dialogue in her blog post. Read more
Come to Dialogue with Aetna Foundation’s Garth Graham, Mar. 9, 2017
Garth Graham, MD, MPH, will deliver the opening keynote address at the Dialogue for Action® conference. We talked to Dr. Graham about his work to improve health equity across the country. Read more
Why you should attend the 2017 Dialogue for Action®, Feb. 24, 2017
We are two months away from the 19th annual Dialogue for Action® on Cancer Screening & Prevention. This cutting-edge conference is being held in an exciting new location, the Hilton McLean Tysons Corner, right outside Washington, D.C. Read more
No woman should die of cervical cancer Jan. 19, 2017
In the United States, cervical cancer is becoming less common thanks to increased vaccinations, improved screening rates and better treatments. But incidence and death rates remain high among women in underserved areas across the country. Read more